Iribarren C

Temporal stability of fecal metabolomic profiles in irritable bowel syndrome.

Iribarren C, Savolainen O, Sapnara M, ..., Magnusson MK, Öhman L

Neurogastroenterol. Motil. 36 (3) e14741 [2024-03-00; online 2024-01-19]

Chalmers Mass Spectrometry Infrastructure [Collaborative]

Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids.

Holst LM, Iribarren C, Sapnara M, ..., Magnusson MK, Öhman L

Int J Mol Sci 23 (24) - [2022-12-07; online 2022-12-07]

Chalmers Mass Spectrometry Infrastructure [Collaborative]

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids.

Iribarren C, Nordlander S, Sundin J, ..., Simrén M, Öhman L

Neurogastroenterol. Motil. 34 (10) e14390 [2022-10-00; online 2022-04-29]

Chalmers Mass Spectrometry Infrastructure [Service] Integrated Microscopy Technologies Gothenburg [Service]

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.

Ahluwalia B, Iribarren C, Magnusson MK, ..., Simrén M, Öhman L

Cells 10 (6) - [2021-06-10; online 2021-06-10]

Chalmers Mass Spectrometry Infrastructure [Service]